易方达恒生港股通创新药ETF
(159316.sz ) 易方达基金管理有限公司
基金类型指数型基金(ETF)成立日期2025-03-21总资产规模39.82亿 (2025-12-31) 基金场内规模39.82亿 (2025-12-31) 基金净值1.2647 (2025-12-31) 收盘价格1.2570 (2025-12-31) 收盘价涨跌幅-1.18%成交金额2.56亿折价率0.61%基金经理成曦管理费用率0.50%管托费用率0.10% (2025-11-18) 持仓换手率172.28% (2025-06-30) 成立以来分红再投入年化收益率29.75% (598 / 5510) 融资融券余额占场内资产规模比例1.56% (融资余额6,211.65万融券余额02025-12-30)
备注 (1): 双击编辑备注
发表讨论

易方达恒生港股通创新药ETF(159316) - 基金对比

最后更新于:2025-12-31

数据选项
非全收益率指数点位的计算不包含分红再投入,所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
比较起始时间为2025-12-31,最多展示50条数据。
日期易方达恒生港股通创新药ETF - 相对起始点分红再投入收益率沪深300 - 相对起始点收益率
2025-12-3129.75%38.33%
2025-12-3031.37%38.97%
2025-12-2932.03%38.61%
2025-12-2635.00%39.14%
2025-12-2535.06%38.71%
2025-12-2435.21%38.45%
2025-12-2336.10%38.05%
2025-12-2236.16%37.78%
2025-12-1937.15%36.48%
2025-12-1835.27%36.02%
2025-12-1734.53%36.83%
2025-12-1634.15%34.37%
2025-12-1535.31%36.00%
2025-12-1241.55%36.87%
2025-12-1139.44%36.01%
2025-12-1040.00%37.19%
2025-12-0941.02%37.38%
2025-12-0842.64%38.08%
2025-12-0545.20%36.97%
2025-12-0444.93%35.84%
2025-12-0342.36%35.37%
2025-12-0244.90%36.07%
2025-12-0146.87%36.73%
2025-11-2847.52%35.24%
2025-11-2748.89%34.91%
2025-11-2647.71%34.97%
2025-11-2545.14%34.16%
2025-11-2444.25%32.89%
2025-11-2139.76%33.06%
2025-11-2046.38%36.39%
2025-11-1945.02%37.08%
2025-11-1846.06%36.48%
2025-11-1748.51%37.38%
2025-11-1451.63%38.28%
2025-11-1352.53%40.48%
2025-11-1245.63%38.81%
2025-11-1142.05%38.99%
2025-11-1042.21%40.27%
2025-11-0740.18%39.79%
2025-11-0643.86%40.22%
2025-11-0543.39%38.25%
2025-11-0442.66%37.99%
2025-11-0347.01%39.03%
2025-10-3144.03%38.65%
2025-10-3039.08%40.72%
2025-10-2941.54%41.85%
2025-10-2841.59%40.18%
2025-10-2743.49%40.90%
2025-10-2442.63%39.25%
2025-10-2342.67%37.62%